The mutant cardiac troponin I (cTnIR193H) interacts with HDAC1, reducing PDE4D levels in cardiomyocytes through promoter degradation, which contributes to the development of restrictive cardiomyopathy [44]. This evidence concerns the gene HDAC1 and restrictive cardiomyopathy.